Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/BONS stock hub

TLV/BONS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TLV/BONSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

471.9M

Tel Aviv Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TLV/BONS

In the news

Latest news · TLV/BONS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-3,788.1

P25 n/aP50 n/aP75 n/a

ROIC-145.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TLV/BONS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

ILS

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	IL
Employees	42
Employees Change	-7%
Employees Change Percent	-14.29
Enterprise value	ILA 480.6M
Exchange	Tel Aviv Stock Exchange
Financial currency	ILS
First seen	2026-05-10
Industry	Biotechnology
Isin	IL0004850116
Last refreshed	2026-05-10
Market cap	ILA 471.9M
Price	ILA 40.4
Price currency	ILA
Sector	Healthcare
Sic	2836
Symbol	tlv/BONS
Website	https://bonus-bio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.19%
EV Earnings	-19.62x
EV/FCF	-32.16x
FCF yield	-3.17%
P/B ratio	-83.32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	ILA -24.5M
Net Income Growth Quarters	3%
Net Income Growth Years	4%
Profit Per Employee	ILA -583,095
ROA	-76.45
Roa5y	-47.28
ROCE	-1,641.9
ROE	-3,788.1
Roe5y	-843.9
ROIC	-145.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.67%
Cagr1y	112.74%
Cagr3y	39.43%
Cagr5y	-19.96%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	ILA 15.4M
Cash	ILA 228,000
Current Assets	ILA 1.8M
Current Liabilities	ILA 14M
Debt	ILA 8.9M
Debt FCF	ILA -0.6
Equity	ILA -5.7M
Interest Coverage	-34.23
Liabilities	ILA 21.1M
Long Term Assets	ILA 13.7M
Long Term Liabilities	ILA 7.1M
Net Cash	ILA -8.7M
Net Cash By Market Cap	ILA -1.84
Tangible Book Value	ILA -5.7M
Tangible Book Value Per Share	ILA -0
WACC	8.93

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.13
Net Working Capital	ILA -10.7M
Quick ratio	0.06
Working Capital	ILA -12.2M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-31.18%
1Y total return	112.63%
200-day SMA	32.37
3Y total return	171.14%
50-day SMA	42.01
50-day SMA vs 200-day SMA	50over200
5Y total return	-67.15%
All Time High	175
All Time High Change	-76.91%
All Time High Date	2021-08-15
All Time Low	9
All Time Low Change	348.89%
All Time Low Date	2024-12-17
ATR	2.6
Beta	0.86
Beta1y	0.44
Beta2y	0.49
Ch YTD	60.96
High	41.8
High52	60.9
High52 Date	2026-01-14
High52ch	-33.66%
Low	40.4
Low52	18.4
Low52 Date	2025-05-08
Low52ch	119.57%
Ma50ch	-3.84%
Price vs 200-day SMA	24.8%
RSI	46.48
RSI Monthly	62.41
RSI Weekly	48.64
Sharpe ratio	1.49x
Sortino ratio	2.75
Tr YTD	60.96
Tr1m	3.06%
Tr1w	-4.94%
Tr3m	2.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ILA -23.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	638,285,068%
Net Borrowing	-1,490,000
Shares Insiders	45.36%
Shares Institutions	0.68%
Shares Out	1,168,135,311
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ILA -16.4M
Average Volume	1,081,584.75x
Bv Per Share	-0
CAPEX	ILA -12,000
Ch10y	-31.18
Ch1m	3.06
Ch1w	-4.94
Ch1y	112.6
Ch3m	2.8
Ch3y	171.1
Ch5y	-67.15
Ch6m	84.48
Change	-2.65%
Change From Open	-0.74
Close	41.5
Days Gap	-1.93
Depreciation Amortization	1,541,000
Dollar Volume	25,314,357.2
Earnings Date	2026-04-13
EBIT	ILA -23.8M
EBITDA	ILA -22.2M
EPS	ILA -0.02
F Score	1
FCF	ILA -14.9M
FCF EV Yield	-3.11x
FCF Per Share	ILA -0.01
Financing CF	8,415,000
Fiscal Year End	December
Founded	1,981
Investing CF	-12,000
Is Primary Listing	1
Last Earnings Date	2025-11-26
Last Report Date	2025-12-31
Ma150	34.93
Ma150ch	15.65%
Ma20	41.04
Ma20ch	-1.56%
Net CF	-6,631,000
Open	40.7
Position In Range	0
Ppne	13,312,000
Price Date	2026-05-08
Relative Volume	0.57x
Share Based Comp	1,464,000
Tr6m	84.48%
Volume	626,593

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TLV/BONS pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/BONS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TLV/BONS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.7%

Share of float held by funds and institutions

Insider ownership

+45.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

TLV/BONS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.5

Neutral momentum band

Price vs 200-day MA

+24.8%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

1.49

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TLV/BONS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/BONS stock rating?

tlv/BONS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/BONS analysis?

The full report lives at /stocks/tlv/BONS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/BONS?

The latest report frames tlv/BONS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/BONS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.